Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231

Código QR

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231

Abstract Introduction Studies using different assays and technologies showed highly promising diagnostic value of plasma phosphorylated (P-)tau levels for Alzheimer’s disease (AD). We aimed to compare six P-tau Simoa assays, including three P-tau181 (Eli Lilly, ADx, Quanterix), one P-tau217 (Eli Lil...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sherif Bayoumy, Inge M. W. Verberk, Ben den Dulk, Zulaiga Hussainali, Marissa Zwan, Wiesje M. van der Flier, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Jeroen Vanbrabant, Erik Stoops, Eugeen Vanmechelen, Jeffrey L. Dage, Charlotte E. Teunissen
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Alzheimer’s disease Blood biomarkers P-tau181 P-tau217 P-tau231 Phosphorylated tau proteins Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/9a80f98ef3db432c84a8599a0bf54390
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

To target Tau pathologies, we must embrace and reconstruct their complexities
por: Galina Limorenko, et al.
Publicado: (2021)

Simple, Single-Shot Phosphoproteomic Analysis of Heat-Stable Tau Identifies Age-Related Changes in pS235- and pS396-Tau Levels in Non-human Primates
por: Shannon N. Leslie, et al.
Publicado: (2021)

Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein
por: Gaoping Lin, et al.
Publicado: (2021)

A Computational Model of the Trans-Synaptic Spread of Pathogenic Tau in Early Alzheimer’s Disease
por: Bashir Sbaiti, et al.
Publicado: (2021)

Differential Effects of Human P301L Tau Expression in Young versus Aged Mice
por: Holly C. Hunsberger, et al.
Publicado: (2021)

Detección de b-Amiloide, Proteína TAU Hiperfosforilada y Ubiquitina por Técnica de Inmunohistoquímica en Cerebros de Caninos Mayores de 10 Años
por: Briones S,Flavio, et al.
Publicado: (2010)

NMR Studies of Tau Protein in Tauopathies
por: Kristine Kitoka, et al.
Publicado: (2021)

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: James R. Hall, et al.
Publicado: (2021)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Moxin Wu, et al.
Publicado: (2021)

Erratum: Behavioral Abnormalities in Knockout and Humanized Tau Mice
por: Frontiers Production Office
Publicado: (2021)

Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease
por: Mar Cuadrado-Tejedor, et al.
Publicado: (2021)

Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
por: Cai Z, et al.
Publicado: (2013)

Amorphous aggregation of tau in the presence of titanium dioxide nanoparticles: biophysical, computational, and cellular studies
por: Fardanesh A, et al.
Publicado: (2019)

Biomarcadores y Marcadores de Imagen de la Enfermedad de Alzheimer
por: Pardi,P.C, et al.
Publicado: (2017)

Mechanical Stretching-Induced Traumatic Brain Injury Is Mediated by the Formation of GSK-3β-Tau Complex to Impair Insulin Signaling Transduction
por: Pei-Wen Cheng, et al.
Publicado: (2021)

MALAT1 Regulated mTOR-Mediated Tau Hyperphosphorylation by Acting as a ceRNA of miR144 in Hippocampus Cells Exposed to High Glucose
por: Lu C, et al.
Publicado: (2021)

Hyperphosphorylation of Tau Due to the Interference of Protein Phosphatase Methylesterase-1 Overexpression by MiR-125b-5p in Melatonin Receptor Knockout Mice
por: Han Zhao, et al.
Publicado: (2021)

Study of partial and average conditional Kendall’s tau
por: Gijbels Irène, et al.
Publicado: (2021)

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
por: Chihiro Sato, et al.
Publicado: (2021)

De Altamira y Levene a Tau Anzoátegui (pasando por García-Gallo). Tres aproximaciones al derecho indiano
por: García-Huidobro,Joaquín, et al.
Publicado: (2017)

Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
por: Rebekka Kühn, et al.
Publicado: (2021)

Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence
por: Qian Ge, et al.
Publicado: (2021)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
por: Hu S, et al.
Publicado: (2020)

Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology
por: Jianfeng Wu, et al.
Publicado: (2021)

Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes
por: Mauro Montalbano, et al.
Publicado: (2021)

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
por: Edmond Teng, et al.
Publicado: (2021)

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
por: Guo YJ, et al.
Publicado: (2016)

Microtubule proteins and their post-translational forms in the cerebrospinal fluid of patients with paraparesis associated with HTLV-I infection and in SH-SY5Y cells: An in vitro model of HTLV-I-induced disease
por: MALDONADO,HORACIO, et al.
Publicado: (2008)

Postoperative 24-h Acute Sleep Deprivation Improves Learning and Memory Through Inhibition of Tau Phosphorylation in the Hippocampal Neurons of Splenectomized Rats
por: Zhang Y, et al.
Publicado: (2020)

Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model
por: Valentina Latina, et al.
Publicado: (2021)

Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis
por: Alessandra Pagano, et al.
Publicado: (2021)

PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107
por: Holly Fowle, et al.
Publicado: (2021)

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
por: Biju Bhargavan, et al.
Publicado: (2021)

La teoría de la neuroinmunomodulación en enfermedades neurodegenerativas: nuevas evidencias científicas
por: Morales,Inelia, et al.
Publicado: (2015)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

La neuroinflamación como factor detonante del desarrollo de la enfermedad de Alzheimer
por: Morales G,Inelia, et al.
Publicado: (2010)

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
por: Shorena Janelidze, et al.
Publicado: (2020)

Evaluación dinámica de control solar lumínico. Propuestas en una biblioteca de arquitectura moderna en Santiago
por: Jeannette Auristela Roldán Rojas, et al.
Publicado: (2020)

Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum
por: Nathalie I. V. Nilsson, et al.
Publicado: (2021)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
por: Geraldine Zimmer-Bensch, et al.
Publicado: (2021)